Lung Volume Reduction Surgery

medical tourism Lung Volume Reduction Surgery

Medical Tourism for Lung Volume Reduction Surgery (LVRS) offers patients with severe emphysema access to high-quality, affordable care at leading international hospitals. Top destinations like India, Turkey, Thailand, and Germany provide advanced VATS and robotic LVRS procedures at 40-60% lower costs than Western countries ( $18, 000 -$ 45,000), performed by experienced thoracic surgeons at JCI-accredited facilities such as Apollo Hospitals (India) and Bumrungrad (Thailand).

You searched for — 0 results found.

No products found.

What is Lung Volume Reduction Surgery (LVRS)?

LVRS is a therapeutic surgical procedure that removes damaged portions of the lungs in patients with severe emphysema/COPD, improving breathing capacity and quality of life.

Who Needs LVRS?

Severe emphysema patients (upper lobe predominant)
Those with hyperinflated lungs compromising diaphragm function
Patients who fail to improve with medications/pulmonary rehab

Surgical Approaches

1. Median Sternotomy (Open Approach)

Traditional method with single chest incision
Allows bilateral lung access in one operation

2. Video-Assisted Thoracoscopic Surgery (VATS)

Minimally invasive (3-4 small incisions)
Faster recovery, less pain than open surgery

3. Robotic-Assisted LVRS

Enhanced precision with 3D visualization
Growing adoption at advanced centers

The LVRS Procedure Step-by-Step

General anesthesia with double-lumen intubation
Identification and removal of 20-30% most damaged lung tissue
Stapling/sealing of resection margins
Chest tube placement for drainage

Recovery Timeline

Phase	Duration	Key Milestones
Hospital Stay	5-10 days	Chest tube removal, pain control
Early Recovery	2-4 weeks	Short walks, breathing exercises
Full Recovery	3-6 months	Gradual return to daily activities

Benefits of LVRS

30-50% improvement in lung function tests
Reduced shortness of breath (dyspnea)
Increased exercise tolerance
Possible reduced oxygen dependency

Risks & Complications

Air leaks (most common, often resolve spontaneously)
Pneumonia/respiratory failure
Arrhythmias (5-10% of cases)
Mortality risk (2-5% in major trials)

LVRS vs. Alternatives

Treatment	Best For	Pros/Cons
LVRS	Upper lobe emphysema	Durable benefits but surgical risks
Bronchoscopic Valves	Heterogeneous emphysema	Less invasive but may require removal
Transplant	End-stage disease	Greatest benefit but donor limitations

Long-Term Outcomes

NETT Trial Data: 50% of patients maintain benefits for 5+ years
Combined with pulmonary rehab yields best results
Not a cure but significant symptom relief. Click to view wmedtor medical tourism health services.